Answers are grounded in this paper and cite their sources.
OBJECTIVE: Chronic venous disease is a progressive disease that often begins with venous symptoms even without visible signs. This systematic review and meta-analysis aimed to evaluate the effectiveness of micronized purified flavonoid fraction (MPFF) in patients with early stage chronic venous disease (Clinical, Etiological, Anatomical, and Pathophysiological C0s-C1). METHODS: A systematic search was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. MEDLINE, Embase, and Cochrane databases were searched from inception until November 2023. Prospective studies (randomized controlled trials and comparative, single-arm, and observational studies) assessing MPFF (1000 mg daily orally) in C0s-C1 patients were included. Outcomes included leg venous symptoms (pain, heaviness, and cramps) and quality of life (QoL). The data were analyzed using a random-effects meta-analysis model. RESULTS: Five studies involving 411 patients were analyzed. The patients' mean age was 40.1 (8.0) years, and 96.6% of them were female. Patients were classified as Clinical, Etiological, Anatomical, and Pathophysiological C1 (80%) and C0s (20%). MPFF significantly reduced pain intensity (mean change [MC], -2.3 cm; 95% confidence interval [CI], -3.1 to -1.6), reduced heaviness (MC, -2.8 cm; 95% CI, -3.5 to -2.1), and improved QoL (MC, -16.0; 95% CI, -20.7 to -11.3). Two studies reported complete resolution of symptoms for pain (100.0%), heaviness (87.9%), and cramps (97.8%). Two studies had a high risk of bias, and the heterogeneity level was frequently high among studies. CONCLUSIONS: The present meta-analysis reinforces the evidence supporting MPFF effectiveness in alleviating venous leg symptoms and improving QoL in C0s-C1 patients and supports the use of MPFF treatment in early disease management.
No takes yet. Share an insight, caveat, or question.
Bouskela et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: